
### [Orphanet:354](http://www.orpha.net/ORDO/Orphanet_354)
**Label:** GM1 gangliosidosis

**Subclasses:** [Orphanet:79256](http://www.orpha.net/ORDO/Orphanet_79256) (GM1 gangliosidosis type 2), [Orphanet:79257](http://www.orpha.net/ORDO/Orphanet_79257) (GM1 gangliosidosis type 3), [Orphanet:79255](http://www.orpha.net/ORDO/Orphanet_79255) (GM1 gangliosidosis type 1), 

**Corr. equiv. classes:** [OMIM:230650](http://purl.obolibrary.org/obo/OMIM_230650), [OMIM:230600](http://purl.obolibrary.org/obo/OMIM_230600), [OMIM:230500](http://purl.obolibrary.org/obo/OMIM_230500), [Orphanet:79255](http://www.orpha.net/ORDO/Orphanet_79255), [Orphanet:79256](http://www.orpha.net/ORDO/Orphanet_79256), [Orphanet:79257](http://www.orpha.net/ORDO/Orphanet_79257), 

**Class expressions from DL-Learner:**

- [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 75.00%
- [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) and [HP:0012444](http://purl.obolibrary.org/obo/HP_0012444) (Brain atrophy) 75.00%
- [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 75.00%
- [HP:0007369](http://purl.obolibrary.org/obo/HP_0007369) (Atrophy/Degeneration affecting the cerebrum) and [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) 75.00%
- [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) and [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) 75.00%
- [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) and [HP:0100547](http://purl.obolibrary.org/obo/HP_0100547) (Abnormality of forebrain morphology) 75.00%
- [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) and [HP:0012444](http://purl.obolibrary.org/obo/HP_0012444) (Brain atrophy) 75.00%
- [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 75.00%
- [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) and [HP:0007369](http://purl.obolibrary.org/obo/HP_0007369) (Atrophy/Degeneration affecting the cerebrum) 75.00%
- [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) and [HP:0007367](http://purl.obolibrary.org/obo/HP_0007367) (Atrophy/Degeneration affecting the central nervous system) 75.00%
- [HP:0002977](http://purl.obolibrary.org/obo/HP_0002977) (Aplasia/Hypoplasia involving the central nervous system) and [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) 75.00%
- [HP:0002977](http://purl.obolibrary.org/obo/HP_0002977) (Aplasia/Hypoplasia involving the central nervous system) and [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) 75.00%
- [HP:0002060](http://purl.obolibrary.org/obo/HP_0002060) (Abnormality of the cerebrum) and [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) 75.00%
- [HP:0002060](http://purl.obolibrary.org/obo/HP_0002060) (Abnormality of the cerebrum) and [HP:0004342](http://purl.obolibrary.org/obo/HP_0004342) (Abnormality of galactoside metabolism) 75.00%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0008166](http://purl.obolibrary.org/obo/HP_0008166) (Decreased beta-galactosidase activity) 75.00%


